HDL Cholesterol

Subscribe to Selected New Research on HDL Cholesterol

8216 relevant articles (216 outcomes, 757 trials/studies) found for this Bio-Agent

Description: Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol.

Also Known As:

Cholesterol, HDL; Cholesterol, HDL2; Cholesterol, HDL3; HDL(2) Cholesterol; HDL(3) Cholesterol; HDL2 Cholesterol; HDL3 Cholesterol; alpha-Lipoprotein Cholesterol; Cholesterol, alpha-Lipoprotein; alpha Lipoprotein Cholesterol; High Density Lipoprotein Cholesterol

Relationship Network

Bio-Agent Context: Research Results

Lipids: 13939

Lipoproteins: 17361

HDL Lipoproteins: 856

HDL Cholesterol: 8216

HDL Cholesterol: 8216

CSL-111: 1

Amino Acids, Peptides, and Proteins

Proteins: 58433

Lipoproteins: 17361

HDL Lipoproteins: 856

HDL Cholesterol: 8216

CSL-111: 1

Experts

1.	Schaefer, Ernst J: 6 articles (04/2008 - 07/2002)
2.	Gotto, Antonio M: 5 articles (01/2005 - 02/2002)
3.	Pitsavos, Christos: 4 articles (10/2007 - 01/2003)
4.	Folsom, Aaron R: 3 articles (10/2008 - 09/2008)
5.	Rosamond, Wayne D: 3 articles (10/2008 - 09/2008)
6.	Kastelein, John J P: 3 articles (09/2008 - 10/2005)
7.	Kuivenhoven, Jan Albert: 3 articles (09/2008 - 10/2005)
8.	Srinivasan, Sathanur R: 3 articles (05/2008 - 07/2006)
9.	Frontini, Maria G: 3 articles (05/2008 - 07/2006)
10.	Ballantyne, Christie M: 3 articles (04/2008 - 11/2003)

Related Diseases

1.	Coronary Disease (Coronary Heart Disease) 06/01/1983 - "Because of its association with longevity and reduced incidence of coronary heart disease, it becomes important to find out how elevated HDL-cholesterol levels are determined. " 08/15/1993 - "For men, improvement in the composite physical activity score significantly correlated with an increase in HDL cholesterol (r = 0.14, p = 0.005) and decreases in body mass index (r = -0.16, p = 0.001) and estimated 10-year coronary heart disease risk score (r = -0.10, p = 0.056). " 03/15/1989 - "The results reveal that HDL-cholesterol percentage had the highest predictive value for risk of future coronary disease; it significantly improved the predictive capability of the logistic regression model, even after adjustment for all other mentioned variables.(ABSTRACT TRUNCATED AT 250 WORDS)" 03/01/1986 - "To test the hypothesis that higher levels of high-density lipoprotein cholesterol (HDL-C) in black men than in white men may offer the former greater protection against coronary heart disease (CAD), the relation between HDL-C and 7-year incidence of CAD was examined in the 5,792 white men and in the 465 black men assigned to the usual-care group of the Multiple Risk Factor Intervention Trial. " 04/01/2000 - "The protective effects of alcoholic against coronary heart disease are mainly related to an increase in HDL cholesterol. " Order ALL the reference details at left...
2.	Atherosclerosis (Atheroma) 11/01/1980 - "Improved approaches to the primary prevention of atherosclerosis may be realized by a better understanding of the inverse relationship of body mass to HDL cholesterol levels." 10/01/1990 - "Research shows that PUFA has little effect on high-density-lipoprotein cholesterol (HDL-C) which is protective against atherosclerosis. " 03/01/2003 - "We hypothesized that elevating LPL activity would cause a reduction of plasma TG and increase in HDL cholesterol, resulting in protection against the development of atherosclerosis. " 03/06/1998 - "These results may help to explain observations in the literature that document an increased risk of atherosclerosis in patients with depressed levels of HDL phospholipid even in the face of normal HDL cholesterol levels." 10/01/2009 - "Therefore, we quantified associations between macronutrient intakes and plasma HDL-cholesterol and TAG, relying on known associations between these factors to test the criterion validity of the FFQ used in the Multi-Ethnic Study of Atherosclerosis (MESA). " Order ALL the reference details at left...
3.	Insulin Resistance 05/01/2000 - "Statins versus placebo significantly lowered plasma total, LDL-, HDL-cholesterol and triglyceride concentrations and improved insulin resistance and Rq and metabolic control. " 12/01/2004 - "We found a significant sex specific effect of the TaqIB CETP polymorphism on the insulin resistance parameters HDL-cholesterol and sdLDL in an Austrian population based study." 05/01/2003 - "Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT)." 02/01/2001 - "This study supports the hypothesis that a low HDL cholesterol associated with insulin resistance in type 2 diabetic and non-diabetic subjects is related to a high plasma CET and a high HL activity." 10/01/2009 - "Only HDL cholesterol and TG were significantly associated with adiposity measures and insulin resistance (measured by homeostasis model assessment [HOMA]) and only in adolescents. " Order ALL the reference details at left...
4.	Syndrome 09/01/2009 - "Some metabolic syndrome components showed statistically significant improvement and also statistically significant correlation with the MDS: waist circumference, HDL-cholesterol, systolic and diastolic blood pressure. " 03/01/2009 - "OBJECTIVES: To know the anthropometric and clinical characteristics of a children population sample, to study the prevalence and concurrence of cardiovascular risk factors in that sample, and to define the prevalence of metabolic syndrome in that population considering the blood pressure, HDL cholesterol, and fasting glycemia values, as well as the anthropometrical measurements. " 12/01/2008 - "Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial." 10/01/2009 - "Statins were shown to significantly lower cardiovascular morbidity and mortality, but treated patients are still left with a high residual risk, in particular for those with metabolic syndrome, type 2 diabetes, or low HDL cholesterol levels. " 05/01/2009 - "However, in contrast to the metabolic syndrome, androgen deprivation therapy increases subcutaneous fat and high density lipoprotein cholesterol. " Order ALL the reference details at left...
5.	Hypertriglyceridemia 04/01/1995 - "Our study indicates that the compound is potentially beneficial for the treatment of hypertriglyceridemia with low HDL cholesterol in diabetes." 08/01/2009 - "In addition, high-density lipoprotein-cholesterol was significantly increased (25%) in the Zucker fatty rat by A-922500 administered at 3 mg/kg. This study provides the first report that inhibition of DGAT-1, the final and only committed step of triglyceride synthesis, with a selective small-molecule inhibitor, significantly reduces serum triglyceride levels in both genetic and diet-induced animal models of hypertriglyceridemia. " 09/01/2007 - "Sustained hypertriglyceridemia and low high-density lipoprotein-cholesterol during the study period was significantly associated with the genetic score. " 04/01/1995 - "The aim of this study was to ascertain whether the compound has the same action in diabetes, because hypertriglyceridemia with low HDL cholesterol is an extremely common concomitant condition in diabetes. " 10/01/1992 - "Therefore, hypertriglyceridemia and hypo-HDL-emia may be the result of the same primary abnormality; as the HDL-cholesterol level is more stable, it is the parameter which will be identified as a protective factor in epidemiological trials. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Cholesterol
2.	Triglycerides (Triacylglycerol)
3.	LDL Cholesterol
4.	Lipoproteins (Lipoprotein)
5.	Insulin (Novolin)
6.	Apolipoprotein A-I (Apolipoprotein A1)
7.	Glucose (Dextrose)
8.	Gemfibrozil (Lopid)
9.	Lipids
10.	Blood Glucose (Blood Sugar)

Related Therapies and Procedures

1.	Renal Dialysis (Hemodialysis)
2.	Drug Therapy (Chemotherapy)
3.	Fat-Restricted Diet (Diet, Fat Restricted)
4.	Aftercare (After-Treatment)
5.	Vegetarian Diet (Vegetarianism)

Best Treatments:
Research Summary Report
on Coronary Disease

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 586 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>